Coordinating Turkey and EU Merger Filings in 2026: Practical Checklist for Cross‑border M&A

Cross-border merger filings turkey teams increasingly find themselves managing two demanding regulatory tracks at once. For in-house counsel, private equity sponsors and deal teams running transactions that trigger both a Turkish and a European Union notification, the practical question is no longer whether to file in both places, but how to sequence, document and manage those parallel processes without triggering avoidable suspension, delay or standstill breaches. This guide translates the legal architecture of the Turkish Competition Authority (TCA) and the European Commission (EC) into an operational checklist: thresholds, timelines, documentation, remedies strategy and a decision matrix for whether to file simultaneously, stagger or seek coordination. It is written for practitioners who need actionable sequencing advice rather than a high-level overview.

Notification thresholds and when to notify: Turkey vs EU

The starting point for any cross-border M&A checklist is a disciplined jurisdictional analysis. The Turkish and European regimes operate independently, apply different thresholds and measure turnover on different geographic footprints. Testing both at the earliest stage of a transaction, ideally before signing, is what prevents nasty surprises later. A deal that appears to be a purely European matter can still capture Turkish revenues that meet the local trigger, and vice versa.

Turkey thresholds under the TCA

Turkish merger control is grounded in the Act on the Protection of Competition No. 4054 and administered by the TCA, with the notifiability of a transaction governed by the applicable communiqué on mergers and acquisitions requiring the authorisation of the Competition Board, currently Communiqué No. 2010/4, as amended. The turnover thresholds that determine when a TCA merger notification is mandatory are periodically revised by the TCA, so the exact figures and any procedural amendments should always be confirmed against the current consolidated text of the communiqué and the TCA’s own merger control pages before a filing decision is made.

In practical terms, a transaction that meets the Turkish turnover-based test is subject to a mandatory, suspensory notification: the parties must not implement the concentration before the TCA has cleared it. That standstill obligation is one of the most important reasons to run the Turkish threshold analysis early, because a deal that closes before Turkish clearance is legally invalid as against the parties until cleared and exposes them to administrative fines for gun-jumping. For cross-border merger filings turkey counsel should treat the Turkish leg not as an afterthought to the EU process but as a co-equal gating item.

EU thresholds under the EUMR

At EU level, jurisdiction is determined by Council Regulation (EC) No 139/2004 (the EU Merger Regulation, or EUMR). The EUMR applies where a concentration has a “Union dimension” measured by combined worldwide and EU-wide turnover thresholds. Where those thresholds are met, the European Commission holds, in principle, exclusive jurisdiction and a mandatory, suspensory notification is required before implementation. As with Turkey, the EU regime is a genuine standstill regime, so early identification of a Union dimension is essential to build a realistic closing timetable.

Practical examples: how thresholds interact in cross-border deals

• Global consolidation with Turkish revenues. Two multinational manufacturers combine. The transaction plainly meets the EUMR thresholds; separately, each party generates Turkish turnover above the local trigger. Both a TCA merger notification and an EC filing are required, and neither clears the other.
• EU-focused deal with a Turkish subsidiary. A European acquirer buys a target whose sales are concentrated in the EU but which owns a Turkish operating company. Even where the EU leg dominates commercially, the Turkish turnover must be tested against the applicable Turkish thresholds; if they are met, a suspensory Turkish filing follows.
• Turkey-heavy deal below the Union dimension. Where the combined turnover does not reach the EUMR thresholds, the EC may have no jurisdiction at all, and the Turkish filing proceeds on its own timetable, a reminder that “EU-first” is not always the right default.

The lesson for any cross-border M&A checklist is that both jurisdictions must be tested on their own terms. Assuming that a European filing “covers” Turkey, or that a small Turkish footprint can be ignored, is the most common early error in cross-border merger filings turkey planning.

Coordinating simultaneous filings: timing, sequencing and practical steps for cross-border merger filings turkey

Once both jurisdictions are confirmed, coordination becomes a project-management exercise as much as a legal one. Simultaneous filings to the EU and Turkey demand a single, integrated calendar, aligned data rooms and clearly allocated ownership. The goal is to keep the two processes moving in parallel so that clearance in one jurisdiction is not held hostage by delay in the other.

Run the pre-notification phase in both jurisdictions

The European Commission strongly favours pre-notification contacts, during which the parties share draft submissions and discuss the scope of information required. Building pre-notification time into the calendar is essential because it is not a fixed period and can extend the overall timetable considerably. In Turkey, early informal communication with the TCA and careful preparation of the notification form reduces the risk of a request for missing information that pauses the review. Running both pre-notification tracks concurrently allows the deal team to identify overlapping information requests and prepare a single evidentiary spine that can be adapted to each regulator’s form.

Build a parallel data room and align disclosures

Both regulators will require overlapping economic and market data, market shares, competitor lists, product and geographic market definitions, customer information and internal strategic documents. The efficient approach is to construct one master data set and then map it to the EC Form CO and the TCA notification form respectively. Critically, confidentiality designations and redactions must be synchronised: inconsistent treatment of the same document across two filings invites questions and can compromise confidentiality claims. For simultaneous filings eu turkey, a shared redaction protocol agreed at the outset saves significant rework.

Sample simultaneous filing calendar

The following textual timeline illustrates how a coordinated process can be sequenced. Actual durations vary with case complexity and regulator workload.

1. Weeks 1–2 (post-signing or advanced negotiation): Confirm thresholds in both jurisdictions; appoint filing owners; open the master data room.
2. Weeks 2–5: Draft the EC Form CO and the TCA notification in parallel; begin EC pre-notification contacts and informal TCA engagement.
3. Weeks 5–7: Finalise redactions and confidentiality designations; localise and translate Turkish documents; resolve pre-notification comments.
4. Week 8: File in both jurisdictions on a coordinated date (or in the priority order dictated by strategy).
5. Post-filing: Manage parallel information requests; monitor the EC Phase I clock and the TCA review period; prepare contingency plans for an in-depth (Phase II or TCA in-depth) inquiry.

Assign clear internal ownership

• Lead antitrust counsel. Owns the overall strategy and the sequencing decision.
• EU filing owner. Manages the Form CO, pre-notification dialogue and Commission information requests.
• Turkey filing owner. Manages the TCA notification, attachments, translations and localisation.
• Data and economics lead. Maintains the master market-share and financial data set feeding both filings.
• Deal counsel. Aligns closing conditions and standstill undertakings with the regulatory timetable.

Deciding whether to file simultaneously or stagger the two notifications turns on the specifics of the deal. Simultaneous filing keeps the timetable tight and signals coordination, but it commits resources on two fronts at once. Staggering, for example, allowing an EU pre-notification process to mature before locking the Turkish filing, can be sensible where the substantive theory of harm is likely to be tested first in one forum. The right answer for any given cross-border merger filings turkey mandate depends on where the competitive risk is concentrated and how tightly the closing calendar is drawn.

Does clearance in one jurisdiction substitute or speed up the other?

A recurring question from transaction teams is whether obtaining clearance in the EU can substitute for, or accelerate, the Turkish process, or the reverse. The short answer is no: the TCA and the European Commission are legally independent authorities applying distinct statutes, and clearance by one does not bind or replace the other. There is no automatic mutual recognition between a Turkish clearance under Law No. 4054 and an EC decision under Regulation 139/2004.

That legal independence does not mean the two processes are hermetically sealed. In practice, the analytical work done for one filing can materially assist the other. Market definitions, competitor data and economic evidence prepared for the Commission can be adapted for the TCA, reducing preparation time even if the legal conclusions differ. Where the EC has examined a concentration and reached a view on the relevant markets, that reasoning may inform, though it does not dictate, how the TCA frames its own assessment of effects on Turkish markets.

Because Turkey is not a Member State, the EUMR referral mechanisms that operate between the Commission and national competition authorities within the EU do not extend to the TCA; coordination is therefore practical and voluntary rather than institutional.

The realistic planning assumption is that each authority will conduct its own review on its own timetable, and that the parties should not build a closing calendar on the premise that one clearance will unlock the other. Where the EU effects of a deal are material, many teams sequence the EC engagement first so that the substantive competitive narrative is stress-tested in that forum, then carry a refined version of that narrative into the Turkish filing. This is a matter of efficiency, not legal necessity: the Turkish standstill obligation remains fully in force regardless of the EU outcome.

Documentation checklist and top causes of delay in Turkey (fixes and templates)

Documentation quality is where cross-border merger filings turkey timelines are most often lost. A complete, well-organised Turkish notification moves smoothly; an incomplete one draws a request for additional information that can pause the substantive review until the gap is filled. Because the Turkish review period effectively runs from the point at which the filing is deemed complete, front-loading documentary rigour is one of the highest-leverage steps a deal team can take.

Mandatory TCA documents

• Completed TCA notification form. The official merger notification form, fully completed in accordance with current TCA guidance and the applicable communiqué.
• Corporate and transaction documents. The transaction agreement or its most recent draft, together with corporate structure charts for the parties before and after the concentration.
• Turnover and financial data. Audited or reliable financial statements evidencing the turnover figures relied upon to establish notifiability.
• Market share and competitive data. Product and geographic market definitions, market share estimates, principal competitors, customers and suppliers, and the basis for any market data provided.
• Competitive assessment. An analysis of horizontal overlaps and vertical relationships affecting Turkish markets.
• Authorisations. Powers of attorney and signatory authority evidencing the representatives’ capacity to file.

Common deficiencies and their fixes

The TCA typically pauses or delays a review when the file is materially incomplete. The most frequent causes, and the practical fixes, include:

• Missing or unsupported market share data. Fix: assemble market share estimates with a clear methodology and source citations before filing; do not leave the market definition open-ended.
• Incomplete financial statements. Fix: confirm that the turnover figures in the form are traceable to the financial statements attached, converted consistently and covering the correct reference period.
• Inadequate competitive assessment. Fix: identify every horizontal overlap and vertical link in Turkish markets, however small, and address each; silence on an overlap invites a follow-up request.
• Improper or missing translations. Fix: provide Turkish translations of key documents in the required form; budget translation time into the pre-filing calendar rather than treating it as a post-filing task.
• Incomplete attachments. Fix: verify that every referenced annex is provided in an accepted format and legible before submission.

Electronic filing: practical steps

The TCA accepts submissions through its official channels, and electronic submission is available for notifications. Deal teams unfamiliar with the process should prepare in advance rather than at the point of filing:

1. Ensure the filing entity or its authorised representative holds the necessary authorisation to act on the company’s behalf.
2. Confirm the accepted file formats and any size limits for attachments before assembling the annex bundle.
3. Organise annexes to mirror the structure of the notification form so that the reviewer can navigate the file efficiently.
4. Verify legibility of scanned corporate documents and translations before submission.
5. Retain submission confirmations and time-stamps as part of the deal record.

A short internal template helps enforce discipline: a single checklist that lists each required document, its owner, its status (drafted / translated / reviewed / submitted) and the confidentiality treatment. For merger filing documents turkey teams, that one-page tracker is often the difference between a clean filing and a request for missing information.

Remedies, undertakings and negotiation strategy across TCA and EC

Where a transaction raises substantive competition concerns, both the TCA and the European Commission may require remedies, behavioural or structural undertakings, referred to as commitments, as a condition of clearance. Coordinating remedies across two regimes is a delicate exercise, because each authority is concerned only with effects in its own territory, yet the parties must offer commitments that are coherent as a package and workable within a single deal structure.

The European Commission generally engages on remedies during the more intensive phase of its review, negotiating commitments that address the specific theories of harm it has identified. The TCA likewise accepts behavioural and structural commitments subject to its review of their adequacy. The timing of when to table remedies differs and must be managed carefully: proposing commitments too early can concede more than necessary, while proposing them too late can push a case into an extended inquiry.

Practical negotiation tips for cross-jurisdictional remedies include:

• Design congruent remedies. Where the same concern arises in both jurisdictions, structure a single divestment or behavioural package that can satisfy both authorities rather than two conflicting commitments.
• Document a global rationale. Maintain a clear internal record of why each remedy addresses the identified harm, so that the logic presented to the EC is consistent with the logic presented to the TCA.
• Prepare separate legal analyses for local effects. Even with a congruent package, tailor the written justification to each regime’s legal test and to the specific Turkish or EU market effects at issue.
• Protect confidentiality. Coordinate what is disclosed to each authority and to third parties so that remedy discussions in one forum do not undermine confidentiality in the other.
• Align closing conditions. Ensure the transaction agreement’s conditions precedent accommodate the possibility of remedies in either jurisdiction and reflect the standstill obligations of both.

The overarching principle is that remedies negotiation is a deal-structuring issue, not merely a compliance step. For cross-border merger filings turkey deal teams, remedies can affect valuation, closing conditions and the viability of the transaction itself, and they should be modelled from the outset rather than treated as an end-stage contingency.

Practical risk matrix and decision checklist: simultaneous file, stagger, or coordinate

Before committing to a filing strategy, work through a short risk matrix and decision checklist. The objective is to weigh suspension risk, timeline risk, confidentiality and business disruption, then choose the sequencing approach that best fits the deal.

• Suspension and standstill risk. Both regimes are suspensory. Confirm that the closing calendar assumes no implementation before clearance in either jurisdiction, and that gun-jumping is avoided across both.
• Timeline risk. Assess whether either filing is likely to move into an extended inquiry. Where a Phase II or TCA in-depth review is plausible, build contingency into the closing long-stop date.
• Confidentiality risk. Determine whether parallel filings increase the exposure of sensitive information and put a synchronised redaction protocol in place.
• Business disruption. Consider the operational cost of running two regulatory processes at once and whether staggering reduces that burden without materially extending the timetable.
• Remedies exposure. Identify early whether either authority is likely to require commitments, and how a remedy in one forum interacts with the deal as a whole.

The decision checklist that follows summarises the choice:

1. Do both thresholds bite? If yes, both filings are mandatory and suspensory.
2. Is the competitive risk concentrated in one forum? If so, consider sequencing that forum first.
3. Is the closing calendar tight? If so, favour simultaneous filing to compress the timetable.
4. Are remedies likely? If so, plan a congruent package and align closing conditions.
5. Is the file fully documented and translated? Only file when complete to avoid a review that stalls on missing information.

Quick reference comparison table, TCA vs European Commission

The table below summarises the key differences between the Turkish and EU merger control regimes for quick reference by deal teams. It is a scannable summary; always confirm current figures and periods against the primary sources.

A well-organised comparison of this kind is a useful anchor for any cross-border M&A checklist. It reminds deal teams that the two regimes differ not only in thresholds but in language, process rhythm and the mechanics of how the review clock starts. For related domestic detail, see Turkey merger control, thresholds & practice, and for context on associated Turkish competition issues, see the discussion of non-compete and non-solicitation restrictions in the Turkey competition context.

Conclusion

Managing cross-border merger filings turkey demands treating the Turkish and EU processes as two co-equal, suspensory tracks that must be planned together from the first threshold analysis to closing. Early, disciplined coordination is more important than ever: test both regimes before signing, build a single master data set mapped to each regulator’s form, allocate clear ownership, and front-load documentary and translation work to avoid a review that stalls on missing information in Turkey. Where remedies are in prospect, design a congruent package and align closing conditions across both jurisdictions rather than negotiating in isolation.

Teams that approach cross-border merger filings turkey as an integrated project, rather than two separate compliance steps, clear their transactions faster and with far less execution risk.

This article is for general information only and does not constitute legal advice. Merger control thresholds, procedures and effective dates are subject to change; jurisdiction-specific advice should be obtained from qualified counsel before making any filing decision.

For related guidance, see the overview of Turkey antitrust and merger thresholds. A dedicated Antitrust practice hub and a filtered directory of Antitrust lawyers in Turkey provide further routes to tailored support.

Sources

1. Turkish Competition Authority (Rekabet Kurumu)
2. Turkish Competition Authority (English)
3. Official Gazette of the Republic of Turkey (Resmî Gazete)
4. EUR-Lex, Council Regulation (EC) No 139/2004 (EUMR)
5. European Commission, DG Competition: Mergers Overview
6. OECD Competition
7. e-Devlet (Turkish Government Portal)